- Hauptnavigation
- Navigation des Hauptbereiches
- Inhalt der Seite
Navigation des Hauptbereiches
Ausgewählte Publikationen und Patente Dr. Cid-Arregui
Ausgewählte Publikationen
Links
Arreygue-Garcia, N, Daneri-Navarro, A, del Toro-Arreola, A, Cid-Arregui, A, Gonzalez-Ramella, O, Jave-Suarez, L, Aguilar-Lemarroy, A, Troyo-Sanroman, R, Bravo-Cuellar, A, Delgado-Rizo, V, Garcia-Iglesias, T, Hernandez-Flores, G and del toro-Arreola, S (2008) Augmented serum levels of soluble MICA and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions. BMC Cancer 8:16
Darnell, G.A., Schroder, W.S., Antalis, T.M., Lambley, E., Major, L., Gardner, J., Birrell, G., Cid-Arregui, A. and Suhrbier A. (2007) The accelerated degradation of the retinoblastoma protein mediated by human papillomavirus E7 requires the cysteine protease calpain. J BIol Chem 282:37492-37500.
Villanueva, R., Morales-Peza, N., Castelán-Sánchez, I., García-Villa, E., Cid-Arregui, A., García-Carrancá, A., López-Bayghen, E. and Gariglio, P. (2006) Heparin (GAG-hed) inhibits LCR activity of Human Papillomavirus type 18 by decreasing AP1 binding. BMC Cancer 6:218
Abstracts
- Cid-Arregui, A., Garcia, G., Jacjinovic, M. and zur Hausen, H. (2005) Nuclear import of HPV-16 E7 occurs via an active mechanism. Eur. J. Cell Biol. 84 (Suppl 55): 45.
Patente
- Cid-Arregui, A. and zur Hausen, H. (2003) Modified HPV E6 and E7 genes and proteins useful for vaccination. PCT Patent file No. 02/03271. EP1243655 (2006); US Patent 7,201,908 B2 (2007)
